In statement, Jim Greenwood, BIO's President and CEO praised the House of Representatives for vote to pass 21st Century Cures legislation that recognizes critical link between research, development, and reimbursement to expedite delivery of breakthrough treatments and cures to patients suffering from life-threatening and debilitating diseases. According to Greenwood, bill represents forward-looking public policies that sustain scientific discovery and promote biomedical advancement.